NCT05609552View on ClinicalTrials.gov

Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2027

Conditions
Tuberculosis
Interventions
COMBINATION_PRODUCT

18F-Pretomanid PET/CT

A bolus of less than or equal to 10 mCi (370 MBq) of 18F-pretomanid will be injected into the intravenous line by slow IV push. Immediately after administration of 18F-pretomanid, dynamic PET acquisition will take place.

Trial Locations (1)

21218

RECRUITING

Johns Hopkins Medical Institutions, Baltimore

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Johns Hopkins University

OTHER